Precision Medicine Market, By Technology (Genomics, Transcriptomics And Epigenomics), By Sequencing Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Sequencing By Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing And Nanopore Sequencing), By Product (Consumables, Instruments And Services), By Application (Oncology, CNS, Immunology, Respiratory Medicine, Infections, And Other Applications), By End User (Diagnostic Tool Companies, Pharma & Biotech Companies, Clinical Laboratories, And Healthcare IT/Big Data Companies), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting to 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

The Precision Medicine Market report highlights market opportunities and competitive scenarios for Precision Medicine Apps on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the Precision Medicine market. The Precision Medicine market has been segmented by technology (genomics, transcriptomics and epigenomics), by sequencing technology (sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, chain termination sequencing and nanopore sequencing), by product (consumables, instruments and services), by application (oncology, CNS, immunology, respiratory medicine, infections, and other applications) and by end user (diagnostic tool companies, pharma & biotech companies, clinical laboratories, and healthcare it/big data companies). Historic back-drop for Precision Medicine market has been analyzed according to organic and inorganic developments to provide precise market size estimations. Also, key factors impacting the growth of the Precision Medicine market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.

Market Segmentation:

By Technology:

  • Genomics
  • Transcriptomics
  • Epigenomics

By Sequencing Technology:

  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing By Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product:

  • Consumables
  • Instruments
  • Services

By Application:

  • Oncology
  • CNS
  • Immunology
  • Respiratory Medicine
  • Infections
  • Other Applications

By End User:

  • Diagnostic Tool Companies
  • Pharma & Biotech Companies
  • Clinical Laboratories
  • Healthcare IT/Big Data Companies

By Region:

  • North America
    • North America, by Country
      • US
      • Canada
      • Mexico
    • North America, by Technology
    • North America, by Sequencing Technology
    • North America, by Product
    • North America, by Application
    • North America, by End User
  • Western Europe
    • Western Europe, by Country
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Western Europe
    • Western Europe, by Technology
    • Western Europe, by Sequencing Technology
    • Western Europe, by Product
    • Western Europe, by Application
    • Western Europe, by End User
  • Asia Pacific
    • Asia Pacific, by Country
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Rest of Asia Pacific
    • Asia Pacific, by Technology
    • Asia Pacific, by Sequencing Technology
    • Asia Pacific, by Product
    • Asia Pacific, by Application
    • Asia Pacific, by End User
  • Eastern Europe
    • Eastern Europe, by Country
      • Russia
      • Turkey
      • Rest of Eastern Europe
    • Eastern Europe, by Technology
    • Eastern Europe, by Sequencing Technology
    • Eastern Europe, by Product
    • Eastern Europe, by Application
    • Eastern Europe, by End User
  • Middle East
    • Middle East, by Country
      • UAE
      • Saudi Arabia
      • Qatar
      • Iran
      • Rest of Middle East
    • Middle East, by Technology
    • Middle East, by Sequencing Technology
    • Middle East, by Product
    • Middle East, by Application
    • Middle East, by End User
  • Rest of the World
    • Rest of the World, by Country
      • South America
      • Africa
    • Rest of the World, by Technology
    • Rest of the World, by Sequencing Technology
    • Rest of the World, by Product
    • Rest of the World, by Application
    • Rest of the World, by End User

Major Companies:

Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly & Company.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for Precision Medicine market on regional and global basis.
  • To identify major segments in Precision Medicine market and evaluate their market shares and demand.
  • To provide a competitive scenario for the Precision Medicine market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of Precision Medicine market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the Precision Medicine market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the Precision Medicine market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]